For the Inventor, By the Inventor

Enter assignee name

BASEL, Switzerland

Universitaet Basel

USPTO Granted Patents = 13

CIPO Patents = 1

Forward Citations = 21

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Simon Ittig (5 out of 6 patents)

Paul Hebeisen (3 out of 49 patents)

Florent Beaufils (3 out of 12 patents)

4. Marlise Amstutz (3 out of 4 patents)

5. Christoph Kasper (3 out of 4 patents)

6. Jean-Baptiste Langlois (2 out of 6 patents)

7. Cécile Arrieumerlou (2 out of 2 patents)

8. Karl Hofbauer (2 out of 4 patents)

9. Beat Ernst (1 out of 13 patents)

10. Ruben Herrendorff (1 out of 4 patents)

11. Andreas Steck (1 out of 4 patents)

12. Fan Yang (1 out of 3 patents)

13. Vladimir Cmiljanovic (1 out of 4 patents)

14. Thomas Bohnacker (1 out of 3 patents)

15. Matthias Wymann (1 out of 5 patents)

13 patents: Sort by Forward Citations

1. 12358955 - Virulence attenuated bacteria based protein delivery (2025-07-15),

2. 12091670 - Bacteria-based protein delivery (2024-09-17),

3. 11992467 - Promotion of lymphatic function (2024-05-28),

4. 11518789 - Virulence attenuated bacteria based protein delivery (2022-12-06),

5. 11166987 - Virulence attenuated bacteria for treatment of malignant solid tumors (2021-11-09),

6. 10889823 - Bacteria-based protein delivery (2021-01-12),

7. 10766874 - Manufacturing process for triazine, pyrimidine and pyridine derivatives (2020-09-08),

8. 10537408 - Dental implant (2020-01-21),

9. 10100031 - Manufacturing process for triazine, pyrimidine and pyridine derivatives (2018-10-16),

10. 9994605 - Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein (2018-06-12),

11. 9556203 - Conformationally restricted P13K and mTOR inhibitors (2017-01-31),

12. 8703139 - Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases (2014-04-22),

13. 8252908 - Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases (2012-08-28),

Universitaet Basel is a leading research university located in Switzerland. With a history dating back over 500 years, the university is renowned for its excellence in both teaching and research. It offers a wide range of programs and degrees across various disciplines, attracting students and scholars from around the world. As one of the top universities in Europe, Universitaet Basel is committed to fostering innovation and discovery through its diverse academic community and state-of-the-art facilities.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#31 in BASEL

#846 in Switzerland

#43,679 in the World

BASEL, Switzerland

Universitaet Basel

Forward Citations = 21

24 inventors:

Simon Ittig (5 out of 6 patents)

Paul Hebeisen (3 out of 49 patents)

Florent Beaufils (3 out of 12 patents)

4. Marlise Amstutz (3 out of 4 patents)

5. Christoph Kasper (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…